Desktop Site |
26 Apr 24 | 14:05 | Open
Equity SME Eq Drv Currency Commodity Corporates
Get Quote
Notices |
S&P BSE SENSEX 73,812.91 -526.53 -0.71 %
Corporate Announcement
  • Security Code500660
    CompanyGLAXOSMITHKLINE PHARMACEUTICALS LTD.
    Exchange Received Time06/10/2017 12:24:57
    Exchange Disseminated Time06/10/2017 12:25:03
    Time Taken00:00:06
     
     
     Statement Of Investors Complaint For Quarter Ended September 2017 | 10/06/17 12:24 
     Pursuant to Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the statement of investor complaints of GlaxoSmithKline Pharmaceuticals Limited for the quarter ended 30th September, 2017.

    Particulars No of complaints
    Complaints pending as on 1st July, 2017. NIL
    Complaints received during 1st July to 30th September, 2017 05
    Complaints resolved during 1st July to 30th September, 2017 05
    Complaints pending as on 30th September, 2017. NIL
    		 
    AttachmentDownload PDF
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(24) 26 Apr 24|14:05 (IST)